Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine
-
Multicenter Study Clinical Trial
Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
To investigate the efficacy and safety of repeated treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity. ⋯ Treatment with NT 201 showed sustained improvements in muscle tone and functionality (median dose 400 units) over a study duration of up to 89 weeks, and was well tolerated during repeated treatments for post-stroke upper limb spasticity.
-
Randomized Controlled Trial
Guided internet-based cognitive behavioural treatment for chronic back pain reduces pain catastrophizing: a randomized controlled trial.
The aim of this study was to investigate whether an Internet-based cognitive behavioural intervention would have an effect on the symptoms of chronic back pain. ⋯ Internet-based cognitive behavioural therapy can serve as a complement for individuals with chronic pain who prefer this treatment and have difficulties accessing specialist treatment facilities.
-
Comparative Study
Bibliometric indicators and core journals in physical and rehabilitation medicine.
The concept of the "standing" of scientific journals (in terms of influence, prestige, popularity, etc.) is multi-dimensional and cannot be captured adequately by a single indicator. The aim of this report is to compare and comment on different bibliometric indicators related to some leading journals in rehabilitation, in order to provide further insights regarding their practical usefulness for Physical and Rehabilitation Medicine. ⋯ The commonly used Journal Impact Factor and the new SCImago Journal Rank indicator are measures of average "impact per paper". Other new measures show potentially useful complementarities with them and warrant further attention. For example, the Eigenfactor score represents a measure of total "citation impact" and seems sufficiently to express the "importance" of a journal. In fact, the information conveyed by the Eigenfactor score corresponds to a general consensus of journal status in Physical and Rehabilitation Medicine, as expressed by the European Consensus Committee on "International Rehabilitation Journals" and captured by a survey among European Physical and Rehabilitation Medicine researchers.
-
Case Reports
Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
Spasticity is a frequent disabling symptom in patients with multiple sclerosis, which contributes to functional deterioration. ⋯ Intrathecal baclofen is well-tolerated and the effect lasts for up to 12 years. A thorough continuous clinical assessment is required because the differentiation between symptoms of multiple sclerosis progression and side-effects of baclofen may be difficult. Intrathecal baclofen should be considered as an option for long-term treatment of patients with advanced spasticity. Pain control can also be achieved by optimized intrathecal baclofen treatment.